共 27 条
[2]
Appelbaum FR, 2005, J CLIN ONCOL, V23, p563S
[3]
Buchner T, 2005, J CLIN ONCOL, V23, p573S
[5]
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2001, 19 (05)
:1405-1413